blog
Patrick Oliver
IP2I shares feedback on the Commission’s roadmap for the IP Action Plan
IP2Innovate has responded to the request for feedback on the upcoming European Commission’s Intellectual Property Action Plan.
We share the Commission’s view that “well-calibrated and balanced IP policies can […] boost Europe’s industrial competitiveness” and get the EU back “on track towards economic recovery” from the Covid-19 outbreak crisis. We applaud, in particular, the Commission’s commitment in the roadmap to “continue to monitor the application of the IPR Enforcement Directive to ensure it is effective and balanced, particularly on injunctions.”
To see our response click here.
Share
Other press releases
leconomiste.com
L’UE face au fléau des «chasseurs de brevets»
Some companies are worried about the spread of the patent troll phenomenon in Europe. Some have even sent a letter to Thierry Breton, European Commissioner for Industry, calling for a “balanced approach to intellectual property and measures against non-practicing entities (NPE): legal person with no activity known as Patent Troll”.
Managing IP
NPEs set sights on UPC and more patent acquisition - Blackbird, Dominion Harbor, Acacia, and Harfang IP say the market is hot for patent acquisitions and that litigation opportunities could soon emerge in Europe
Managing IP’s article outlining the views of Non-Practicing Entities (NPEs) on the Unified Patent Court (UPC) points out that several NPEs are gearing up for the launch of the UPC in the following months because the UPC’s centralised system “would make Europe a much easier place to litigate”. NPEs also argue that UPC would provide for another way to litigate in a “market comparable to China or the US”.
Industriekoalition IP2Innovate fordert Patentrechtsreform zur Förderung von Innovation in Deutschland
Das Patentrecht ist ein wesentlicher Eckpfeiler für Innovation und – damit verbunden – für nachhaltiges Wirtschaftswachstum. Es kann dieser Rolle allerdings nur gerecht werden, wenn es die Entwicklung und das Inverkehrbringen komplexer, multifunktionaler Hightech-Produkte wie Autos, Telefone und medizinische Geräte unterstützt. Dies tut das deutsche Patentrecht derzeit nicht! Hauptmangel: Unterlassungsklagen werden automatisch erlassen, ohne alternative, geeignetere Rechtsmittel zu prüfen. Diese Situation schadet der deutschen Industrie.